Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used in Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) to Treat Aortoiliac Occlusive Disease
NCT ID: NCT06872905
Last Updated: 2026-01-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
158 participants
OBSERVATIONAL
2025-05-30
2027-08-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used as a Bridging Stent With Branched and Fenestrated Endografts in the Treatment of Aortic Aneurysms Involving the Renal-Mesenteric Arteries
NCT05143138
GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis Post-Market Clinical Follow-Up (PMCF) Observational Registry
NCT07279649
Evaluation of the GORE® VIABAHN® BALLOON EXPANDABLE ENDOPROSTHESIS (VIABAHN BX)
NCT01961167
Post-Market Registry of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis Implanted in Peripheral Vessels
NCT03720704
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
NCT02080871
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
GORE VIABAHN® VBX Balloon Expandable Endoprosthesis
Patient was implanted with the VBX Device in the aortic and common iliac positions during the CERAB procedure.
GORE VIABAHN® VBX Balloon Expandable Endoprosthesis (VBX)
Treatment of Target Lesions with the VBX Device in the aortic and common iliac positions during the CERAB procedure.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
GORE VIABAHN® VBX Balloon Expandable Endoprosthesis (VBX)
Treatment of Target Lesions with the VBX Device in the aortic and common iliac positions during the CERAB procedure.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patient was implanted with the VBX Device in the aortic position during a CERAB procedure.
3. Patient was treated with the CERAB procedure a minimum of 1 year before enrollment date.
4. Age ≥18 years at the time of CERAB procedure.
5. Obtain patient informed consent or waiver according to local Institutional Review Board (IRB)/Ethics Committee (EC) -
Exclusion Criteria
2. Patient treated with concomitant chimney procedure at time of CERAB procedure (e.g., inferior mesenteric artery, renal artery).
3. Participation in another drug or device investigational study at the time of the CERAB procedure date that can confound the study endpoints.
\-
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
W.L.Gore & Associates
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Leigh Ann O'Banion, M.D.
Role: PRINCIPAL_INVESTIGATOR
University of California, San Francisco
Michele Antonello, M.D.
Role: PRINCIPAL_INVESTIGATOR
Azienda Ospedaliero-Universitaria di Padova
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of California
Fresno, California, United States
Mayo Clinic Rochester
Rochester, Minnesota, United States
Cooper University Hospital
Camden, New Jersey, United States
Rutgers
New Brunswick, New Jersey, United States
Research Foundation SUNY Buffalo
Buffalo, New York, United States
Mount Sinai Medical Center
New York, New York, United States
Ohio State University Medical Center
Columbus, Ohio, United States
University Of Pennsylvania
Philadelphia, Pennsylvania, United States
Wellmont Holston Valley Medical Center
Kingsport, Tennessee, United States
The University of Texas Austin
Austin, Texas, United States
Carilion Clinic
Roanoke, Virginia, United States
Marshfield Hospital
Marshfield, Wisconsin, United States
Azienda Ospedaliero-Universitaria di Padova
Padua, , Italy
Ospedale di Circolo e Fondazione Macchi
Varese, , Italy
Amsterdam UMC Research BV
Amsterdam, , Netherlands
Franciscus
Rotterdam, , Netherlands
Hospital General Universitario de Alicante
Alicante, , Spain
Greater Glasgow Health Board
Glasgow, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Jessica Gallegos
Role: primary
Samantha Knight
Role: primary
Jonelle O'Shea
Role: primary
Marie Macor
Role: primary
Dawn Holler
Role: primary
Bridget Coyle
Role: primary
Subhashish Das
Role: primary
Carolina Reyes
Role: primary
Ashley Bowen
Role: primary
Andrea Stapper
Role: primary
Yili Zhong
Role: primary
Angela Varsho
Role: primary
Gabriele Piffaretti
Role: primary
Rutger Lely
Role: primary
Jerome van Brussel
Role: primary
Elisabeth Cruces Fuentes
Role: primary
Martin Hennessy
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VBX 24-03
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.